Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries.
Advances in therapy
View this publicationAdvances in therapy
View this publicationChemical science
View this publicationJAMA oncology
View this publicationAdvances in therapy
View this publicationiScience
View this publicationAdvances in therapy
View this publicationCancer research
View this publicationJournal of critical care
View this publicationFrontiers in medicine
View this publicationNature medicine
View this publication